Axitinib is a kinase inhibitor used to treat advanced renal cell carcinoma after failure of a previous systemic therapy.
FDA,2012.01
Used for treating advanced renal cell carcinoma following failure of a prior sys···【more】
Release date:2026-01-05Recommended:13
Lucius Version of Axitinib: Dosage and Administration, Indications, PrecautionsI···【more】
Release date:2025-12-08Recommended:49